Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,565 | 4,450 | 1,657 | 3,333 | 5,001 |
| Marketable Securities | 108 | 751 | N/A | N/A | N/A |
| Receivables | 426 | 473 | 443 | 538 | 303 |
| Inventories | 26 | 60 | N/A | N/A | 0 |
| Other current assets | 0 | 561 | 710 | 703 | 696 |
| TOTAL | $7,654 | $7,111 | $3,628 | $5,206 | $6,173 |
| Non-Current Assets | |||||
| PPE Net | 526 | 528 | 512 | 505 | 515 |
| Investments And Advances | 2,086 | 1,007 | 1,096 | 1,127 | 1,191 |
| Other Non-Current Assets | 3,433 | 3,710 | 3,710 | 3,689 | 3,728 |
| TOTAL | $6,044 | $5,244 | $5,317 | $5,321 | $5,434 |
| Total Assets | $13,698 | $12,355 | $8,945 | $10,526 | $11,607 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 393 | 315 | 321 | 367 | 311 |
| Accrued Expenses | 1,301 | 1,134 | 1,865 | 2,136 | 2,119 |
| Other current liabilities | 11 | 11 | 11 | 12 | 12 |
| TOTAL | $3,692 | $3,439 | $4,376 | $4,666 | $4,844 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 104 | 237 | 237 | 124 |
| Other Non-Current Liabilities | 105 | 1,302 | 3,898 | 3,961 | 4,097 |
| TOTAL | $1,135 | $1,326 | $4,053 | $4,131 | $4,100 |
| Total Liabilities | $4,828 | $4,765 | $8,429 | $8,797 | $8,945 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,031 | 2,861 | 2,447 | 2,442 | 2,442 |
| Common Shares | 29 | 28 | 25 | 24 | 24 |
| Retained earnings | -37,942 | -30,549 | -28,743 | -26,771 | -25,642 |
| Other shareholders' equity | -2,331 | -2,606 | -2,768 | -3,277 | -3,472 |
| TOTAL | $8,870 | $7,590 | $516 | $1,729 | $2,662 |
| Total Liabilities And Equity | $13,698 | $12,355 | $8,945 | $10,526 | $11,607 |